MT2022-01: MSCs for ALD

Clinical trial NCT06030648 · SUSPENDED

Trial details

NCT number: NCT06030648
Sponsor: Masonic Cancer Center, University of Minnesota
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Cerebral Adrenoleukodystrophy

Start date: 2023-08-28
Primary completion: 2027-05-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.